Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 253

1.

Prophylaxis and therapy for Chikungunya virus infection.

Couderc T, Khandoudi N, Grandadam M, Visse C, Gangneux N, Bagot S, Prost JF, Lecuit M.

J Infect Dis. 2009 Aug 15;200(4):516-23. doi: 10.1086/600381.

PMID:
19572805
2.

A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease.

Couderc T, Chrétien F, Schilte C, Disson O, Brigitte M, Guivel-Benhassine F, Touret Y, Barau G, Cayet N, Schuffenecker I, Desprès P, Arenzana-Seisdedos F, Michault A, Albert ML, Lecuit M.

PLoS Pathog. 2008 Feb 8;4(2):e29. doi: 10.1371/journal.ppat.0040029.

3.

Chikungunya infection: an emerging rheumatism among travelers returned from Indian Ocean islands. Report of 47 cases.

Simon F, Parola P, Grandadam M, Fourcade S, Oliver M, Brouqui P, Hance P, Kraemer P, Ali Mohamed A, de Lamballerie X, Charrel R, Tolou H.

Medicine (Baltimore). 2007 May;86(3):123-37.

4.

Update: chikungunya fever diagnosed among international travelers--United States, 2006.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2007 Mar 30;56(12):276-7.

5.

Chikungunya fever: an epidemiological review of a re-emerging infectious disease.

Staples JE, Breiman RF, Powers AM.

Clin Infect Dis. 2009 Sep 15;49(6):942-8. doi: 10.1086/605496. Review.

PMID:
19663604
6.

Clinical and virological characterization of imported cases of Chikungunya fever.

Pfeffer M, Zöller G, Essbauer S, Tomaso H, Behrens-Riha N, Löscher T, Dobler G.

Wien Klin Wochenschr. 2008;120(19-20 Suppl 4):95-100. doi: 10.1007/s00508-008-1035-0.

PMID:
19066782
7.

Chikungunya virus infection of corneal grafts.

Couderc T, Gangneux N, Chrétien F, Caro V, Le Luong T, Ducloux B, Tolou H, Lecuit M, Grandadam M.

J Infect Dis. 2012 Sep 15;206(6):851-9. doi: 10.1093/infdis/jis296. Epub 2012 Jun 15.

PMID:
22706183
8.

Chikungunya fever: a re-emerging viral infection.

Chhabra M, Mittal V, Bhattacharya D, Rana U, Lal S.

Indian J Med Microbiol. 2008 Jan-Mar;26(1):5-12. Review.

9.

Chikungunya fever: CNS infection and pathologies of a re-emerging arbovirus.

Das T, Jaffar-Bandjee MC, Hoarau JJ, Krejbich Trotot P, Denizot M, Lee-Pat-Yuen G, Sahoo R, Guiraud P, Ramful D, Robin S, Alessandri JL, Gauzere BA, Gasque P.

Prog Neurobiol. 2010 Jun;91(2):121-9. doi: 10.1016/j.pneurobio.2009.12.006. Epub 2009 Dec 23. Review.

PMID:
20026374
10.

Prospective study of Chikungunya virus acute infection in the Island of La Réunion during the 2005-2006 outbreak.

Staikowsky F, Talarmin F, Grivard P, Souab A, Schuffenecker I, Le Roux K, Lecuit M, Michault A.

PLoS One. 2009 Oct 28;4(10):e7603. doi: 10.1371/journal.pone.0007603.

11.

Investigation of an outbreak of chikungunya in Malegaon Municipal areas of Nasik district, Maharashtra (India) and its control.

Kumar K, Chhabra M, Katyal R, Patnaik PK, Kukreti H, Rai A, Saxena VK, Mittal V, Lal S.

J Vector Borne Dis. 2008 Jun;45(2):157-63. Retraction in: J Vector Borne Dis. 2008 Sep;45(3):1 p following 253.

PMID:
18592845
12.

Evaluation of the first commercial chikungunya virus indirect immunofluorescence test.

Litzba N, Schuffenecker I, Zeller H, Drosten C, Emmerich P, Charrel R, Kreher P, Niedrig M.

J Virol Methods. 2008 Apr;149(1):175-9. doi: 10.1016/j.jviromet.2008.01.004. Epub 2008 Feb 21.

PMID:
18294706
13.

Development of a sensitive real-time reverse transcriptase PCR assay with an internal control to detect and quantify chikungunya virus.

Laurent P, Le Roux K, Grivard P, Bertil G, Naze F, Picard M, Staikowsky F, Barau G, Schuffenecker I, Michault A.

Clin Chem. 2007 Aug;53(8):1408-14. Epub 2007 Jun 22.

14.

[Chikungunya fever--expanded distribution of a re-emerging tropical infectious disease].

Stock I.

Med Monatsschr Pharm. 2009 Jan;32(1):17-26. Review. German.

PMID:
19205134
15.

Chikungunya virus envelope-specific human monoclonal antibodies with broad neutralization potency.

Warter L, Lee CY, Thiagarajan R, Grandadam M, Lebecque S, Lin RT, Bertin-Maghit S, Ng LF, Abastado JP, Desprès P, Wang CI, Nardin A.

J Immunol. 2011 Mar 1;186(5):3258-64. doi: 10.4049/jimmunol.1003139. Epub 2011 Jan 28.

16.

Chikungunya virus: possible impact on transfusion medicine.

Petersen LR, Stramer SL, Powers AM.

Transfus Med Rev. 2010 Jan;24(1):15-21. doi: 10.1016/j.tmrv.2009.09.002. Review.

PMID:
19962571
17.

A single mutation in chikungunya virus affects vector specificity and epidemic potential.

Tsetsarkin KA, Vanlandingham DL, McGee CE, Higgs S.

PLoS Pathog. 2007 Dec;3(12):e201.

18.

Deciphering the protective role of adaptive immunity to CHIKV/IRES a novel candidate vaccine against Chikungunya in the A129 mouse model.

Chu H, Das SC, Fuchs JF, Suresh M, Weaver SC, Stinchcomb DT, Partidos CD, Osorio JE.

Vaccine. 2013 Jul 18;31(33):3353-60. doi: 10.1016/j.vaccine.2013.05.059. Epub 2013 May 29.

19.

No evidence of chikungunya virus and antibodies shortly before the outbreak on Sri Lanka.

Panning M, Wichmann D, Grywna K, Annan A, Wijesinghe S, Kularatne SA, Drosten C.

Med Microbiol Immunol. 2009 May;198(2):103-6. doi: 10.1007/s00430-009-0110-0. Epub 2009 Feb 18.

PMID:
19224245
20.

Type I IFN controls chikungunya virus via its action on nonhematopoietic cells.

Schilte C, Couderc T, Chretien F, Sourisseau M, Gangneux N, Guivel-Benhassine F, Kraxner A, Tschopp J, Higgs S, Michault A, Arenzana-Seisdedos F, Colonna M, Peduto L, Schwartz O, Lecuit M, Albert ML.

J Exp Med. 2010 Feb 15;207(2):429-42. doi: 10.1084/jem.20090851. Epub 2010 Feb 1.

Supplemental Content

Support Center